Brief: Tissue Regenix Group Terminates Strategic Review, No Longer In Offer Period
08/04/2025 07:31
April 8 (Reuters) - Tissue Regenix Group PLC TRX.L: CONCLUSION OF STRATEGIC REVIEW & OFFER PERIOD TISSUE REGENIX GROUP PLC - EXPECTS 2024 REVENUE TO INCREASE BY 8% TO $28.4M TERMINATES STRATEGIC REVIEW, NO LONGER IN OFFER PERIOD ((Reuters.Briefs@thomsonreuters.com;;))